Trial Profile

GeneVieve

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 May 2010

At a glance

  • Drugs Reximmune C; Rexin-G
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms GeneVieve
  • Sponsors Epeius Biotechnologies Corporation
  • Most Recent Events

    • 24 May 2010 Trial acronym added.
    • 24 May 2010 Interim results will be presented at ASCO on June 6 2010, according to a Epeius Biotechnologies Corporation media release
    • 05 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top